Radioimmunoassay Market is Expected to Reach a Market Value of USD 526.16 Million by 2026

Radioimmunoassay Market is forecasted to grow at 3.6% for 2019-2026 with factors such as increasing procedure cost and drawbacks of the surgery will restrict the growth of the market in emerging economies

Radioimmunoassay market has shown an exceptional penetration in developed economies of Europe. Increasing occurrence of infectious diseases among geriatric population and rising number of clinical trials will boost the growth of the market.

Radioimmunoassay Market Scenario

According to Data Bridge Market Research the radioimmunoassay market is attaining a significant growth due to factors such as rising incidence of cancer, endocrine disorders along with various other infectious diseases and increased use of radioimmunoassay procedure in pharmaceutical industry for drug testing, rising awareness among the people regarding cancer and other infectious diseases and increasing need of quality and error free diagnosis which will surge the growth of the market.

Now the question is which are the other regions that radioimmunoassay market is targeting? Data Bridge Market Research has forecasted a large growth in Asia-Pacific radioimmunoassay market during the forecast period of 2019-2026. The Data bridge market research new reports highlight the major growth factors and opportunities in the radioimmunoassay market

For More Analysis on the radioimmunoassay market request for a briefing with our analysts

New Radioimmunoassay Market Development

  • In July 2018, DIAsource ImmunoAssays SA collaborated with ZenTech. Under the agreement ZenTech will transfer their radioimmunoassay portfolio to the second largest supplier of radioimmunoassay across the globe. This will increase the quality of radioimmunoassay and other solutions to their customer.

Scope of the Radioimmunoassay Market

Radioimmunoassay market is segmented on the basis of countries into U.S., Canada, Mexico in North America, Brazil, Argentina, Rest of South America as a part of South America, Germany, France, U.K., Italy, Spain, Netherlands, Belgium, Russia, Turkey, Switzerland, Rest of Europe in Europe, China, Japan, India, Australia, Singapore, Thailand, Malaysia, South Korea, Indonesia, Philippines, Rest of Asia Pacific (APAC)as a part of Asia-Pacific (APAC), U.A.E, Egypt, Saudi Arabia, South Africa, Israel,  Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

  • All country based analysis of the radioimmunoassay market is further analyzed based on maximum granularity into further segmentation. On the basis of product type, the market is segmented into reagents, kits and analysers. Based on end-user, the market is segmented into hospitals, pharmaceutical and biotechnology industry, CRO, academic institutions and clinical diagnostic laboratories, contract research organizations. The applications covered for the report are research and clinical diagnostic.
  • Radioimmunoassay is an in-vitro immunoassay that is used to measure concentrates of substances and presence of antigen by using antibodies. The technique of radioimmunoassay has revolutionized research and clinical practice in many areas such as diagnosis of allergies, blood banking, endocrinology and others.

To know more about the study

Key Pointers Covered in the Radioimmunoassay Market Industry Trends and Forecast to 2026

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the report

  • MP Biomedicals.
  • Beckman Coulter, Inc.
  • DRG International, Inc.
  • Cisbio
  • DiaSorin S.p.A.
  • Izotop
  • Euro Diagnostica AB
  • PerkinElmer, Inc.
  • IBL International
  • DIAsource ImmunoAssays SA
  • EMD Millipore
  • Stratec Biomedical AG
  • Izotop

Above are the key players covered in the report to know about more and exhaustive list of Radioimmunoassay companies contact us

Research Methodology: Global Radioimmunoassay Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@